1 - 25 of 147 results for author:"Moore P." in Literature citations
Results Customize
› Repeat search in UniProtKB (538)
| Characterization of an early passage Merkel cell polyomavirus-positive Merkel cell carcinoma cell line, MS-1, and its growth in NOD scid gamma mice. Guastafierro A., Feng H., Thant M., Kirkwood J.M., Chang Y., Moore P.S., Shuda M. J. Virol. Methods 187:6-14(2013) · UniProtKB (4) |
| Complete genome sequence of canine papillomavirus type 9. Yuan H., Luff J., Zhou D., Wang J., Affolter V., Moore P., Schlegel R. J. Virol. 86:5966-5966(2012) · UniProtKB (7) |
| RNA interference characterization of proteins discovered by proteomic analysis of pancreatic cancer reveals function in cell growth and survival. Lee C.N., Heidbrink J.L., McKinnon K., Bushman V., Olsen H., FitzHugh W., Li A., Van Orden K., He T., Ruben S.M. et al. Pancreas 41:84-94(2012) · Mapped (8) |
| Human Merkel cell polyomavirus small T antigen is an oncoprotein targeting the 4E-BP1 translation regulator. Shuda M., Kwun H.J., Feng H., Chang Y., Moore P.S. J. Clin. Invest. 121:3623-3634(2011) · Mapped (1) |
| Cellular and viral factors regulating Merkel cell polyomavirus replication. Feng H., Kwun H.J., Liu X., Gjoerup O., Stolz D.B., Chang Y., Moore P.S. PLoS ONE 6:e22468-e22468(2011) · UniProtKB (15) |
| Accelerated turnover of taste bud cells in mice deficient for the cyclin-dependent kinase inhibitor p27Kip1. Harrison T.A., Smith Adams L.B., Moore P.D., Perna M.K., Sword J.D., Defoe D.M. BMC Neurosci 12:34-34(2011) · Mapped (4) |
| Asymmetric assembly of Merkel cell polyomavirus large T-antigen origin binding domains at the viral origin. Harrison C.J., Meinke G., Kwun H.J., Rogalin H., Phelan P.J., Bullock P.A., Chang Y., Moore P.S., Bohm A. J. Mol. Biol. 409:529-542(2011) · UniProtKB (1) |
| Merkel cell polyomavirus large T antigen disrupts lysosome clustering by translocating human Vam6p from the cytoplasm to the nucleus. Liu X., Hein J., Richardson S.C., Basse P.H., Toptan T., Moore P.S., Gjoerup O.V., Chang Y. J. Biol. Chem. 286:17079-17090(2011) · Mapped (2) |
| The central repeat domain 1 of Kaposi's sarcoma-associated herpesvirus (KSHV) latency associated-nuclear antigen 1 (LANA1) prevents cis MHC class I peptide presentation. Kwun H.J., da Silva S.R., Qin H., Ferris R.L., Tan R., Chang Y., Moore P.S. Virology 412:357-365(2011) · Mapped (992) |
| The design and synthesis of novel N-hydroxyformamide inhibitors of ADAM-TS4 for the treatment of osteoarthritis. De Savi C., Pape A., Cumming J.G., Ting A., Smith P.D., Burrows J.N., Mills M., Davies C., Lamont S., Milne D. et al. Bioorg. Med. Chem. Lett. 21:1376-1381(2011) · Mapped (1) |
| Polyomavirus infection in a free-ranging California sea lion (Zalophus californianus) with intestinal T-cell lymphoma. Colegrove K.M., Wellehan J.F. Jr., Rivera R., Moore P.F., Gulland F.M., Lowenstine L.J., Nordhausen R.W., Nollens H.H. J. Vet. Diagn. Invest. 22:628-632(2010) · UniProtKB (6) |
| Human Flt3L generates dendritic cells from canine peripheral blood precursors: implications for a dog glioma clinical trial. Xiong W., Candolfi M., Liu C., Muhammad A.K., Yagiz K., Puntel M., Moore P.F., Avalos J., Young J.D., Khan D. et al. PLoS ONE 5:e11074-e11074(2010) · Mapped (3) |
| Merkel cell polyomavirus-infected Merkel cell carcinoma cells require expression of viral T antigens. Houben R., Shuda M., Weinkam R., Schrama D., Feng H., Chang Y., Moore P.S., Becker J.C. J. Virol. 84:7064-7072(2010) · UniProtKB (4) |
| beta(2)-adrenergic receptor promoter haplotype influences spirometric response during an acute asthma exacerbation. Moore P.E., Williams S.M., Gebretsadik T., Jiang L., Minton P.L., Shintani A., Phillips Iii J.A., Dawson E.P., Hartert T.V. Clin Transl Sci 1:155-161(2008) · Mapped (5) |
| Identification of early interstitial lung disease in an individual with genetic variations in ABCA3 and SFTPC. Crossno P.F., Polosukhin V.V., Blackwell T.S., Johnson J.E., Markin C., Moore P.E., Worrell J.A., Stahlman M.T., Phillips J.A., Loyd J.E. et al. Chest 137:969-973(2010) · Mapped (7) |
| The Ero1alpha-PDI redox cycle regulates retro-translocation of cholera toxin. Moore P., Bernardi K.M., Tsai B. Mol. Biol. Cell 21:1305-1313(2010) · Mapped (5) |
| Structure and sequence variation of the canine perforin gene. Neta M., Wen X., Moore P.F., Bienzle D. Vet. Immunol. Immunopathol. 133:314-320(2010) · UniProtKB (1) |
| Structures of triacetyloleandomycin and mycalamide A bind to the large ribosomal subunit of Haloarcula marismortui. Gurel G., Blaha G., Steitz T.A., Moore P.B. Antimicrob. Agents Chemother. 53:5010-5014(2009) · Mapped (29) |
| Functional and genetic analysis of coreceptor usage by dualtropic HIV-1 subtype C isolates. Singh A., Page T., Moore P.L., Allgaier R.L., Hiramen K., Coovadia H.M., Walker B.D., Morris L., Ndung'u T. Virology 393:56-67(2009) · UniProtKB (29) |
| Genetic variants of GSNOR and ADRB2 influence response to albuterol in African-American children with severe asthma. Moore P.E., Ryckman K.K., Williams S.M., Patel N., Summar M.L., Sheller J.R. Pediatr. Pulmonol. 44:649-654(2009) · Mapped (9) |
| GYY4137, a novel hydrogen sulfide-releasing molecule, protects against endotoxic shock in the rat. Li L., Salto-Tellez M., Tan C.H., Whiteman M., Moore P.K. Free Radic. Biol. Med. 47:103-113(2009) · Mapped (2) |
| U2504 determines the species specificity of the A-site cleft antibiotics: the structures of tiamulin, homoharringtonine, and bruceantin bound to the ribosome. Gurel G., Blaha G., Moore P.B., Steitz T.A. J. Mol. Biol. 389:146-156(2009) · Mapped (29) |
| Structural basis for the inhibition mechanism of human cystathionine gamma-lyase, an enzyme responsible for the production of H(2)S. Sun Q., Collins R., Huang S., Holmberg-Schiavone L., Anand G.S., Tan C.-H., van-den-Berg S., Deng L.-W., Moore P.K., Karlberg T. et al. J. Biol. Chem. 284:3076-3085(2009) · UniProtKB (1) · Mapped (2) |
| T antigen mutations are a human tumor-specific signature for Merkel cell polyomavirus. Shuda M., Feng H., Kwun H.J., Rosen S.T., Gjoerup O., Moore P.S., Chang Y. Proc. Natl. Acad. Sci. U.S.A. 105:16272-16277(2008) · UniProtKB (29) |
| The identification of 2-(1H-indazol-4-yl)-6-(4-methanesulfonyl-piperazin-1-ylmethyl)-4-morpholin-4-yl-thieno[3,2-d]pyrimidine (GDC-0941) as a potent, selective, orally bioavailable inhibitor of class I PI3 kinase for the treatment of cancer . Folkes A.J., Ahmadi K., Alderton W.K., Alix S., Baker S.J., Box G., Chuckowree I.S., Clarke P.A., Depledge P., Eccles S.A. et al. J. Med. Chem. 51:5522-5532(2008) · Mapped (1) |